NCT06668948View on ClinicalTrials.gov

The Prognostic Role of Fibrinogen to Albumin Ratio in Acute Leukemia Patients

Not yet recruitingOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

November 1, 2025

Study Completion Date

December 1, 2025

Conditions
Patients with Acute Leukemia
All Listed Sponsors
lead

Assiut University

OTHER

NCT06668948 - The Prognostic Role of Fibrinogen to Albumin Ratio in Acute Leukemia Patients | Biotech Hunter | Biotech Hunter